|
| 36217921 | Real-World Trends in the Evaluation of Medical Products. | Am J Epidemiol | 2023 |
| 34165790 | Uncontrolled Extensions of Clinical Trials and the Use of External Controls-Scoping Opportunities and Methods. | Clin Pharmacol Ther | 2022 |
| 35663113 | Multi-institutional distributed data networks for real-world evidence about medical devices: building unique device identifiers into longitudinal data (BUILD). | JAMIA Open | 2022 |
| 36001322 | Keeping Meta-analyses Fresh. | JAMA Netw Open | 2022 |
| 36393894 | Advancing the Real-World Evidence for Medical Devices through Coordinated Registry Networks. | BMJ Surg Interv Health Technol | 2022 |
| 35333307 | Comment on: Risk of major adverse cardiovascular events in patients initiating biologics/apremilast for psoriatic arthritis: a nationwide cohort study. | Rheumatology (Oxford) | 2022 |
| 33454352 | Quantifying bias in epidemiologic studies evaluating the association between acetaminophen use and cancer. | Regul Toxicol Pharmacol | 2021 |
| 34517075 | A systematic assessment of the epidemiologic literature regarding an association between acetaminophen exposure and cancer. | Regul Toxicol Pharmacol | 2021 |
| 34628108 | Challenges of evaluating and modelling vaccination in emerging infectious diseases. | Epidemics | 2021 |
| 34846532 | Evaluating the Value of a New Prediction Model for Gastric Cancer. | JAMA Netw Open | 2021 |
| 34075572 | Signal Detection and Methodological Limitations in a Real-World Registry: Learnings from the Evaluation of Long-Term Safety Analyses in PSOLAR. | Drug Saf | 2021 |
| 33982938 | Comparative Effectiveness of Famotidine in Hospitalized COVID-19 Patients. | Am J Gastroenterol | 2021 |
| 34311042 | Letter to the editor concerning the article: "Comparative safety and benefit-risk profile of biologics and oral treatments for moderate-to-severe plaque psoriasis: A network meta-analysis of clinical trial data". | J Am Acad Dermatol | 2021 |
| 33436424 | STaRT-RWE: structured template for planning and reporting on the implementation of real world evidence studies. | BMJ | 2021 |
| 32514736 | Designing, Conducting, Monitoring, and Analyzing Data from Pragmatic Randomized Clinical Trials: Proceedings from a Multi-stakeholder Think Tank Meeting. | Ther Innov Regul Sci | 2020 |
| 31816040 | Learning from electronic health records across multiple sites: A communication-efficient and privacy-preserving distributed algorithm. | J Am Med Inform Assoc | 2020 |
| 33284462 | Prospective meta-analyses and Cochrane's role in embracing next-generation methodologies. | Cochrane Database Syst Rev | 2020 |
| 32964514 | Methods for external control groups for single arm trials or long-term uncontrolled extensions to randomized clinical trials. | Pharmacoepidemiol Drug Saf | 2020 |
| 32338068 | Acute pancreatitis risk in type 2 diabetes patients treated with canagliflozin versus other antihyperglycemic agents: an observational claims database study. | Curr Med Res Opin | 2020 |
| 32500272 | Channeling Bias in the Analysis of Risk of Myocardial Infarction, Stroke, Gastrointestinal Bleeding, and Acute Renal Failure with the Use of Paracetamol Compared with Ibuprofen. | Drug Saf | 2020 |
| 30909296 | How Confident Should We Be About Recommendations Based on Network Meta-analyses? | Ann Intern Med | 2019 |
| 35047771 | Determining value of Coordinated Registry Networks (CRNs): a case of transcatheter valve therapies. | BMJ Surg Interv Health Technol | 2019 |
| 31661431 | Practical help for specifying the target difference in sample size calculations for RCTs: the DELTA<sup>2</sup> five-stage study, including a workshop. | Health Technol Assess | 2019 |
| 31651373 | Correction to: Choosing the target difference and undertaking and reporting the sample size calculation for a randomised controlled trial - the development of the DELTA2 guidance. | Trials | 2019 |
| 31302205 | A randomized trial provided new evidence on the accuracy and efficiency of traditional vs. electronically annotated abstraction approaches in systematic reviews. | J Clin Epidemiol | 2019 |
| 31553465 | What Are Factorial Experiments and Why Can They Be Helpful? | JAMA Netw Open | 2019 |
| 31456304 | Diabetic ketoacidosis in patients with type 2 diabetes treated with sodium glucose co-transporter 2 inhibitors versus other antihyperglycemic agents: An observational study of four US administrative claims databases. | Pharmacoepidemiol Drug Saf | 2019 |
| 31597627 | A guide to prospective meta-analysis. | BMJ | 2019 |
| 31066478 | Comment on "How pharmacoepidemiology networks can manage distributed analyses to improve replicability and transparency and minimize bias". | Pharmacoepidemiol Drug Saf | 2019 |
| 28898514 | Risk of lower extremity amputations in people with type 2 diabetes mellitus treated with sodium-glucose co-transporter-2 inhibitors in the USA: A retrospective cohort study. | Diabetes Obes Metab | 2018 |
| 29938883 | Comparative effectiveness of canagliflozin, SGLT2 inhibitors and non-SGLT2 inhibitors on the risk of hospitalization for heart failure and amputation in patients with type 2 diabetes mellitus: A real-world meta-analysis of 4 observational databases (OBSERVE-4D). | Diabetes Obes Metab | 2018 |
| 30400926 | DELTA<sup>2</sup> guidance on choosing the target difference and undertaking and reporting the sample size calculation for a randomised controlled trial. | Trials | 2018 |
| 30480665 | Overview and experience of the YODA Project with clinical trial data sharing after 5 years. | Sci Data | 2018 |
| 30646216 | Evaluating the Potential Benefits of Using Sustained Response as a Prognostic Factor in Intermediate Hepatocellular Carcinoma Following Treatment With Conventional Chemoembolization. | JAMA Netw Open | 2018 |
| 30305155 | Choosing the target difference and undertaking and reporting the sample size calculation for a randomised controlled trial - the development of the DELTA<sup>2</sup> guidance. | Trials | 2018 |
| 30560792 | DELTA<sup>2</sup> guidance on choosing the target difference and undertaking and reporting the sample size calculation for a randomised controlled trial. | BMJ | 2018 |
| 29494348 | Methodological challenges in indirect treatment comparisons: spotlight on a recent comparison of long-acting injectable aripiprazole versus paliperidone palmitate in the treatment of schizophrenia. | Int Clin Psychopharmacol | 2018 |
| 27859769 | Association between complete response and outcomes in transplant-eligible myeloma patients in the era of novel agents. | Eur J Haematol | 2017 |
| 28448895 | Incidence of diabetic ketoacidosis among patients with type 2 diabetes mellitus treated with SGLT2 inhibitors and other antihyperglycemic agents. | Diabetes Res Clin Pract | 2017 |
| 29260229 | Guidelines for the Content of Statistical Analysis Plans in Clinical Trials. | JAMA | 2017 |
| 28785887 | Quality of Meta-Analyses for Randomized Trials in the Field of Hypertension: an Updated and Improved Systematic Review. | Curr Hypertens Rep | 2017 |
| 28809079 | Changes in the use of erythropoiesis-stimulating agents (ESAs) and red blood cell transfusion in patients with cancer amidst regulatory and reimbursement changes. | Pharmacoepidemiol Drug Saf | 2017 |
| 28780741 | Channeling in the Use of Nonprescription Paracetamol and Ibuprofen in an Electronic Medical Records Database: Evidence and Implications. | Drug Saf | 2017 |
| 28606102 | Choosing the target difference ('effect size') for a randomised controlled trial - DELTA<sup>2</sup> guidance protocol. | Trials | 2017 |
| 27388570 | Baseline characteristics and treatment-emergent risk factors associated with cerebrovascular event and death with risperidone in dementia patients. | Br J Psychiatry | 2016 |
| 27876082 | Evaluating Data Abstraction Assistant, a novel software application for data abstraction during systematic reviews: protocol for a randomized controlled trial. | Syst Rev | 2016 |
| 27697753 | Recommendations to improve adverse event reporting in clinical trial publications: a joint pharmaceutical industry/journal editor perspective. | BMJ | 2016 |
| 27755384 | Quality of meta-analyses for randomized trials in the field of hypertension: a systematic review. | J Hypertens | 2016 |
| 27363818 | Regulatory approval of pharmaceuticals without a randomised controlled study: analysis of EMA and FDA approvals 1999-2014. | BMJ Open | 2016 |
| 25749803 | Use of adjectives in abstracts when reporting results of randomized, controlled trials from industry and academia. | Drugs R D | 2015 |